首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Memorias do instituto oswaldo cruz

缩写:MEM I OSWALDO CRUZ

ISSN:0074-0276

e-ISSN:1678-8060

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2436
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Letícia Bomfim Campos,Nathália Alves Araújo de Almeida,Marcia Maria Amendola Pires et al. Letícia Bomfim Campos et al.
Background: Single-nucleotide polymorphisms (SNPs) can influence the hepatitis C virus (HCV) infection and progression. ABCB1-gene SNPs - c.1236C>T, c.2677G>T and c.3435C>T - are associated with drug efficacy, hepatotoxic...
Leticia Miranda Santos Lery,Paulo Ricardo Batista Leticia Miranda Santos Lery
Klebsiella pneumoniae (Kp) is currently a top priority for the development of alternative therapeutic strategies, according to the World Health Organisation, due to serious concerns regarding infections caused by multiple drug resistant (MD...
Yasmim Mendes Rocha,Lyanna Rodrigues Ribeiro,Gabriel Acácio de Moura et al. Yasmim Mendes Rocha et al.
Background: Chagas disease (CD) is caused by Trypanosoma cruzi. Treatment is based on benznidazole (Bz), although it has significant limitations, such as low efficacy in the chronic phase. Therefore, the search for new th...
João Paulo Sales Oliveira-Correia,Hélcio Reinaldo Gil-Santana,Cleber Galvão João Paulo Sales Oliveira-Correia
Background: Triatoma infestans complex comprises 39 species of South American triatomines, organised into different subcomplexes. These species act as vectors of the protozoan Trypanosoma cruzi, the etiological agent of C...
Ludmila Ferreira de Almeida Fiuza,Ketlym da Conceição,Krislayne Nunes et al. Ludmila Ferreira de Almeida Fiuza et al.
Background: Chagas disease (CD) and Leishmaniasis, caused by Trypanosoma cruzi and Leishmania species, are treated with outdated drugs that are toxic and have limited efficacy. New therapeutic alternatives are therefore n...
Gabriel Parreiras Estolano da Silveira,Laís Bastos da Fonseca,Rita Estrela et al. Gabriel Parreiras Estolano da Silveira et al.
Background: Benznidazole (BZN) has been used for more than fifty years in the treatment of Chagas disease (CD). It is produced by only three pharmaceutical companies worldwide: Lafepe (Brazil); Elea (Argentina) and Licons...
Ana Maria Murta Santi,Davi Alvarenga Lima,Silvane Maria Fonseca Murta Ana Maria Murta Santi
The treatment of Chagas disease (CD) has relied for more than five decades on two drugs, benznidazole (BZ) and nifurtimox (NTX), both with significant limitations and severe adverse effects. Their limited efficacy during the chronic phase u...
Kartika Doerdjan-Ramoutar,Jerry Toelsie,Amandine Guidez et al. Kartika Doerdjan-Ramoutar et al.
Background: Dengue outbreaks pose a significant public health risk in Suriname, with challenges in mosquito surveillance and limited data on insecticide resistance hampering control efforts. ...
Felipe Ridolfi,Gustavo Amorim,David W Haas et al. Felipe Ridolfi et al.
Background: Tuberculosis/human immunodeficiency virus (TB/HIV) coinfection is associated with advanced HIV disease and variable responses to antiretroviral therapy (ART). ...
Brena Ramos Athaydes,Mariane Vedovatti Monfardini,Juliana Santa Ardisson et al. Brena Ramos Athaydes et al.
Background: Children experience Coronavirus disease 2019 (COVID-19) often with milder symptoms but severe outcomes. Objectives: To comp...